Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 250,000 shares at $20.00 ($5.0M) on 2022-07-22, disclosed to the SEC on 2022-07-26.
Open-market purchase of $5.0M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |
| RVMD | BUY | 2022-03-21 | $6.8M | — | Filing → |